Top Markets
#1 Black Phoenix Black Phoenix +733.92%
#2 Biconomy Biconomy +28.18%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#4 TENDIES TENDIES +21.95%
#5 MetaDAO MetaDAO +19.52%
#6 THORChain THORChain +19.00%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +17.65%
#8 Moolah Moolah +16.24%
#9 Pons Pons +13.92%
#10 THORChain Yield THORChain Yield +13.85%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Classement en actions #4864
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Prix de l'action
$3.50
Capitalisation boursière
$3.22B
Changement (1 jour)
1.17%
Changement (1 an)
-50.77%
Pays
CN
Échange Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Catégorie

Healthcare
Ratio P/B pour Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Hebei Changshan Biochemical Pharmaceutical Co., Ltd., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Hebei Changshan Biochemical Pharmaceutical Co., Ltd. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH